This educational video playlist provides patients with a detailed, easy-to-understand overview of the Pembrolizumab (an immunotherapy drug) and Lenvatinib (a targeted therapy drug) combination regimen used for treating advanced or recurrent endometrial cancer.
The goal of this chemo education series is to empower patients with the knowledge needed to manage their treatment journey effectively. We break down the regimen's logistics, including how and when the medicines are administered (by mouth or intravenously) and the recommended dosing schedule.
Crucially, the playlist provides in-depth information on potential side effects (e.g., hypertension, hypothyroidism, diarrhea, fatigue) and practical strategies for managing them. You'll also learn about common monitoring procedures and when to contact your healthcare team.